Integration Is the Key to Success: How Will the New SCZ Therapies Fit Into Clinical Treatment Paradigms?

Published: April 30, 2024, 4 a.m.

Host: Philip D. Harvey, PhD
\n\n Guest: Martin Strassnig, MD
\n\n\n \n

This series of bite-sized episodes will provide important information on cognitive impairment associated with schizophrenia. Drs. Philip Harvey and Martin Strassnig discuss the pathophysiology, diagnosis, and emerging therapies to treat cognitive impairment associated with schizophrenia.